1887

Abstract

Chikungunya virus (CHIKV) is a re-emerging mosquito-borne virus, which causes epidemics of fever, joint pain and rash. There are three genotypes: West African, East/Central/South/Africa (ECSA) and Asian, with the latter two predominant globally. Genotype-specific differences in clinical presentations, virulence and immunopathology have been described. Macrophages are key cells in immune responses against CHIKV. Circulating blood monocytes enter tissue to differentiate into monocyte-derived macrophages (MDMs) in response to CHIKV infection at key replication sites such as lymphoid organs and joints. This study analyses differences in replication and induced immune mediators following infection of MDMs with Asian and ECSA CHIKV genotypes. Primary human MDMs were derived from residual blood donations. Replication of Asian (MY/06/37348) or ECSA (MY/08/065) genotype strains of CHIKV in MDMs was measured by plaque assay. Nineteen immune mediators were measured in infected cell supernatants using multiplexed immunoassay or ELISA. MY/08/065 showed significantly higher viral replication at 24 h post-infection (h p.i.) but induced significantly lower expression of proinflammatory cytokines (CCL-2, CCL-3, CCL-4, RANTES and CXCL-10) and the anti-inflammatory IL-1Ra compared to MY/06/37348. No differences were seen at later time points up to 72 h p.i. During early infection, MY/08/065 induced lower proinflammatory immune responses in MDMs. , this may lead to poorer initial control of viral infection, facilitating CHIKV replication and dissemination to other sites such as joints. This may explain the consistent past findings that the ECSA genotype is associated with greater viremia and severity of symptoms than the Asian genotype. Knowledge of CHIKV genotype-specific immunopathogenic mechanisms in human MDMs is important in understanding of clinical epidemiology, biomarkers and therapeutics in areas with co-circulation of different genotypes.

Funding
This study was supported by the:
  • Ministry of Higher Education Malaysia (Award FRGS/1/2018/SKK11/UM/01/3)
    • Principle Award Recipient: ChongLong Chua
Loading

Article metrics loading...

/content/journal/jgv/10.1099/jgv.0.001842
2023-04-12
2024-05-14
Loading full text...

Full text loading...

References

  1. Robinson MC. An epidemic of virus disease in Southern Province, Tanganyika Territory, in 1952-53. I. Clinical features. Trans R Soc Trop Med Hyg 1955; 49:28–32 [View Article] [PubMed]
    [Google Scholar]
  2. Borgherini G, Poubeau P, Staikowsky F, Lory M, Le Moullec N et al. Outbreak of chikungunya on Reunion Island: early clinical and laboratory features in 157 adult patients. Clin Infect Dis 2007; 44:1401–1407 [View Article] [PubMed]
    [Google Scholar]
  3. Weaver SC, Forrester NL. Chikungunya: evolutionary history and recent epidemic spread. Antiviral Res 2015; 120:32–39 [View Article] [PubMed]
    [Google Scholar]
  4. Lanciotti RS, Valadere AM. Transcontinental movement of Asian genotype chikungunya virus. Emerg Infect Dis 2014; 20:1400–1402 [View Article] [PubMed]
    [Google Scholar]
  5. de Oliveira EC, Fonseca V, Xavier J, Adelino T, Morales Claro I et al. Short report: Introduction of chikungunya virus ECSA genotype into the Brazilian Midwest and its dispersion through the Americas. PLoS Negl Trop Dis 2021; 15:e0009290 [View Article] [PubMed]
    [Google Scholar]
  6. Sourisseau M, Schilte C, Casartelli N, Trouillet C, Guivel-Benhassine F et al. Characterization of reemerging chikungunya virus. PLoS Pathog 2007; 3:e89 [View Article] [PubMed]
    [Google Scholar]
  7. Her Z, Malleret B, Chan M, Ong EKS, Wong S-C et al. Active infection of human blood monocytes by chikungunya virus triggers an innate immune response. J Immunol 2010; 184:5903–5913 [View Article] [PubMed]
    [Google Scholar]
  8. Murray PJ, Wynn TA. Protective and pathogenic functions of macrophage subsets. Nat Rev Immunol 2011; 11:723–737 [View Article] [PubMed]
    [Google Scholar]
  9. Mohd Zim MA, Sam IC, Omar SFS, Chan YF, AbuBakar S et al. Chikungunya infection in Malaysia: comparison with dengue infection in adults and predictors of persistent arthralgia. J Clin Virol 2013; 56:141–145 [View Article] [PubMed]
    [Google Scholar]
  10. Hoarau J-J, Jaffar Bandjee M-C, Krejbich Trotot P, Das T, Li-Pat-Yuen G et al. Persistent chronic inflammation and infection by chikungunya arthritogenic alphavirus in spite of a robust host immune response. J Immunol 2010; 184:5914–5927 [View Article] [PubMed]
    [Google Scholar]
  11. Labadie K, Larcher T, Joubert C, Mannioui A, Delache B et al. Chikungunya disease in nonhuman primates involves long-term viral persistence in macrophages. J Clin Invest 2010; 120:894–906 [View Article] [PubMed]
    [Google Scholar]
  12. Sam IC, Chan YF, Chan SY, Loong SK, Chin HK et al. Chikungunya virus of Asian and Central/East African genotypes in Malaysia. J Clin Virol 2009; 46:180–183 [View Article] [PubMed]
    [Google Scholar]
  13. Sam I-C, Loong S-K, Michael JC, Chua C-L, Wan Sulaiman WY et al. Genotypic and phenotypic characterization of chikungunya virus of different genotypes from Malaysia. PLoS One 2012; 7:e50476 [View Article] [PubMed]
    [Google Scholar]
  14. Bustos Carrillo F, Collado D, Sanchez N, Ojeda S, Lopez Mercado B et al. Epidemiological evidence for lineage-specific differences in the risk of inapparent chikungunya virus infection. J Virol 2019; 93:e01622-18 [View Article] [PubMed]
    [Google Scholar]
  15. Gardner J, Anraku I, Le TT, Larcher T, Major L et al. Chikungunya virus arthritis in adult wild-type mice. J Virol 2010; 84:8021–8032 [View Article] [PubMed]
    [Google Scholar]
  16. Teo T-H, Her Z, Tan JJL, Lum F-M, Lee WWL et al. Caribbean and La Réunion chikungunya virus isolates differ in their capacity to induce proinflammatory Th1 and NK cell responses and acute joint pathology. J Virol 2015; 89:7955–7969 [View Article] [PubMed]
    [Google Scholar]
  17. Ferdowsi S, Abbasi-Malati Z, Pourfathollah AA. Leukocyte reduction filters as an alternative source of peripheral blood leukocytes for research. Hematol Transfus Cell Ther 2021; 43:494–498 [View Article] [PubMed]
    [Google Scholar]
  18. Szklarczyk D, Gable AL, Nastou KC, Lyon D, Kirsch R et al. The STRING database in 2021: customizable protein-protein networks, and functional characterization of user-uploaded gene/measurement sets. Nucleic Acids Res 2021; 49:D605–D612 [View Article] [PubMed]
    [Google Scholar]
  19. Prasad A, Sedlářová M, Balukova A, Ovsii A, Rác M et al. Reactive oxygen species imaging in U937 cells. Front Physiol 2020; 11:552569 [View Article] [PubMed]
    [Google Scholar]
  20. Cook LE, Locke MC, Young AR, Monte K, Hedberg ML et al. Distinct roles of interferon alpha and beta in controlling chikungunya virus replication and modulating neutrophil-mediated inflammation. J Virol 2019; 94:e00841-19 [View Article] [PubMed]
    [Google Scholar]
  21. Guerrero-Arguero I, Høj TR, Tass ES, Berges BK, Robison RA. A comparison of chikungunya virus infection, progression, and cytokine profiles in human PMA-differentiated U937 and murine RAW264.7 monocyte derived macrophages. PLoS One 2020; 15:e0230328 [View Article] [PubMed]
    [Google Scholar]
  22. Felipe VLJ, Paula A V, Silvio U-I. Chikungunya virus infection induces differential inflammatory and antiviral responses in human monocytes and monocyte-derived macrophages. Acta Trop 2020; 211:105619 [View Article] [PubMed]
    [Google Scholar]
  23. Chow A, Her Z, Ong EKS, Chen J, Dimatatac F et al. Persistent arthralgia induced by chikungunya virus infection is associated with interleukin-6 and granulocyte macrophage colony-stimulating factor. J Infect Dis 2011; 203:149–157 [View Article] [PubMed]
    [Google Scholar]
  24. van Duijl-Richter MKS, Hoornweg TE, Rodenhuis-Zybert IA, Smit JM. Early events in chikungunya virus infection-from virus cell binding to membrane fusion. Viruses 2015; 7:3647–3674 [View Article] [PubMed]
    [Google Scholar]
  25. Ng LFP, Chow A, Sun Y-J, Kwek DJC, Lim P-L et al. IL-1beta, IL-6, and RANTES as biomarkers of chikungunya severity. PLoS One 2009; 4:e4261 [View Article] [PubMed]
    [Google Scholar]
  26. Noret M, Herrero L, Rulli N, Rolph M, Smith PN et al. Interleukin 6, RANKL, and osteoprotegerin expression by chikungunya virus-infected human osteoblasts. J Infect Dis 2012; 206:455–7 [View Article] [PubMed]
    [Google Scholar]
  27. Lentscher AJ, McCarthy MK, May NA, Davenport BJ, Montgomery SA et al. Chikungunya virus replication in skeletal muscle cells is required for disease development. J Clin Invest 2020; 130:1466–1478 [View Article] [PubMed]
    [Google Scholar]
  28. McIntyre KW, Stepan GJ, Kolinsky KD, Benjamin WR, Plocinski JM et al. Inhibition of interleukin 1 (IL-1) binding and bioactivity in vitro and modulation of acute inflammation in vivo by IL-1 receptor antagonist and anti-IL-1 receptor monoclonal antibody. J Exp Med 1991; 173:931–939 [View Article] [PubMed]
    [Google Scholar]
  29. Amati A-L, Zakrzewicz A, Siebers R, Wilker S, Heldmann S et al. Chemokines (CCL3, CCL4, and CCL5) inhibit ATP-induced release of IL-1β by monocytic cells. Mediators Inflamm 2017; 2017:1434872 [View Article] [PubMed]
    [Google Scholar]
  30. Fox JM, Roy V, Gunn BM, Huang L, Edeling MA et al. Optimal therapeutic activity of monoclonal antibodies against chikungunya virus requires Fc-FcγR interaction on monocytes. Sci Immunol 2019; 4:32 [View Article] [PubMed]
    [Google Scholar]
  31. Teng T-S, Kam Y-W, Lee B, Hapuarachchi HC, Wimal A et al. A systematic meta-analysis of immune signatures in patients with acute chikungunya virus infection. J Infect Dis 2015; 211:1925–1935 [View Article] [PubMed]
    [Google Scholar]
  32. Kumar S, Jaffar-Bandjee M-C, Giry C, Connen de Kerillis L, Merits A et al. Mouse macrophage innate immune response to chikungunya virus infection. Virol J 2012; 9:313 [View Article] [PubMed]
    [Google Scholar]
  33. Valdés-López JF, Fernandez GJ, Urcuqui-Inchima S. Interleukin 27 as an inducer of antiviral response against chikungunya virus infection in human macrophages. Cell Immunol 2021; 367:104411 [View Article] [PubMed]
    [Google Scholar]
  34. Schilte C, Couderc T, Chretien F, Sourisseau M, Gangneux N et al. Type I IFN controls chikungunya virus via its action on nonhematopoietic cells. J Exp Med 2010; 207:429–442 [View Article] [PubMed]
    [Google Scholar]
  35. Olagnier D, Scholte FEM, Chiang C, Albulescu IC, Nichols C et al. Inhibition of dengue and chikungunya virus infections by RIG-I-mediated type I interferon-independent stimulation of the innate antiviral response. J Virol 2014; 88:4180–4194 [View Article] [PubMed]
    [Google Scholar]
  36. Kelvin AA, Banner D, Silvi G, Moro ML, Spataro N et al. Inflammatory cytokine expression is associated with chikungunya virus resolution and symptom severity. PLoS Negl Trop Dis 2011; 5:e1279 [View Article] [PubMed]
    [Google Scholar]
  37. Geng T, Lin T, Yang D, Harrison AG, Vella AT et al. A critical role for STING signaling in limiting pathogenesis of chikungunya virus. J Infect Dis 2021; 223:2186–2196 [View Article] [PubMed]
    [Google Scholar]
  38. Herrero LJ, Nelson M, Srikiatkhachorn A, Gu R, Anantapreecha S et al. Critical role for macrophage migration inhibitory factor (MIF) in Ross River virus-induced arthritis and myositis. Proc Natl Acad Sci U S A 2011; 108:12048–12053 [View Article] [PubMed]
    [Google Scholar]
  39. Lin T, Geng T, Harrison AG, Yang D, Vella AT et al. CXCL10 signaling contributes to the pathogenesis of arthritogenic alphaviruses. Viruses 2020; 12:1252 [View Article] [PubMed]
    [Google Scholar]
  40. Chen W, Foo SS, Taylor A, Lulla A, Merits A et al. Bindarit, an inhibitor of monocyte chemotactic protein synthesis, protects against bone loss induced by chikungunya virus infection. J Virol 2015; 89:581–593 [View Article] [PubMed]
    [Google Scholar]
  41. Jain J, Narayanan V, Kumar A, Shrinet J, Srivastava P et al. Establishment and comparison of pathogenicity and related neurotropism in two age groups of immune competent mice, C57BL/6J using an Indian isolate of chikungunya virus (CHIKV). Viruses 2019; 11:578 [View Article] [PubMed]
    [Google Scholar]
  42. Chaaitanya IK, Muruganandam N, Sundaram SG, Kawalekar O, Sugunan AP et al. Role of proinflammatory cytokines and chemokines in chronic arthropathy in CHIKV infection. Viral Immunol 2011; 24:265–271 [View Article] [PubMed]
    [Google Scholar]
  43. Petitdemange C, Becquart P, Wauquier N, Béziat V, Debré P et al. Unconventional repertoire profile is imprinted during acute chikungunya infection for natural killer cells polarization toward cytotoxicity. PLoS Pathog 2011; 7:e1002268 [View Article] [PubMed]
    [Google Scholar]
  44. Teo T-H, Lum F-M, Claser C, Lulla V, Lulla A et al. A pathogenic role for CD4+ T cells during chikungunya virus infection in mice. J Immunol 2013; 190:259–269 [View Article] [PubMed]
    [Google Scholar]
  45. Chen C-I, Clark DC, Pesavento P, Lerche NW, Luciw PA et al. Comparative pathogenesis of epidemic and enzootic chikungunya viruses in a pregnant rhesus macaque model. Am J Trop Med Hyg 2010; 83:1249–1258 [View Article] [PubMed]
    [Google Scholar]
  46. Julander JG, Dagley A, Gebre M, Komeno T, Nakajima N et al. Strain-dependent disease and response to favipiravir treatment in mice infected with chikungunya virus. Antiviral Res 2020; 182:104904 [View Article] [PubMed]
    [Google Scholar]
  47. Langsjoen RM, Haller SL, Roy CJ, Vinet-Oliphant H, Bergren NA et al. Chikungunya virus strains show lineage-specific variations in virulence and cross-protective ability in murine and nonhuman primate models. mBio 2018; 9:e02449-17 [View Article] [PubMed]
    [Google Scholar]
  48. Epelman S, Lavine KJ, Randolph GJ. Origin and functions of tissue macrophages. Immunity 2014; 41:21–35 [View Article] [PubMed]
    [Google Scholar]
  49. Hannemann N, Apparailly F, Courties G. Synovial macrophages: from ordinary eaters to extraordinary multitaskers. Trends Immunol 2021; 42:368–371 [View Article] [PubMed]
    [Google Scholar]
  50. Ordaz-Arias MA, Díaz-Alvarez L, Zúñiga J, Martinez-Sánchez ME, Balderas-Martínez YI. Cyclic attractors are critical for macrophage differentiation, heterogeneity, and plasticity. Front Mol Biosci 2022; 9:807228 [View Article] [PubMed]
    [Google Scholar]
  51. Fear WR, Kesson AM, Naif H, Lynch GW, Cunningham AL. Differential tropism and chemokine receptor expression of human immunodeficiency virus type 1 in neonatal monocytes, monocyte-derived macrophages, and placental macrophages. J Virol 1998; 72:1334–1344 [View Article] [PubMed]
    [Google Scholar]
  52. Lee DH, Ghiasi H. Roles of M1 and M2 macrophages in herpes simplex virus 1 infectivity. J Virol 2017; 91:15 [View Article] [PubMed]
    [Google Scholar]
  53. Gundra UM, Girgis NM, Ruckerl D, Jenkins S, Ward LN et al. Alternatively activated macrophages derived from monocytes and tissue macrophages are phenotypically and functionally distinct. Blood 2014; 123:e110–22 [View Article] [PubMed]
    [Google Scholar]
  54. Ferreira JM, Santos LDS, Oliveira SP, Dos Santos BRC, Dos Santos ACM et al. Chikungunya virus infection outcome: a systematic review of host genetics. Immunol Invest 2021; 50:58–79 [View Article] [PubMed]
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jgv/10.1099/jgv.0.001842
Loading
/content/journal/jgv/10.1099/jgv.0.001842
Loading

Data & Media loading...

Supplements

Supplementary material 1

PDF
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error